McKesson Corp. Stock
McKesson Corp. Stock
McKesson Corp. gained 0.880% compared to yesterday.
McKesson Corp. is currently one of the favorites of our community with 17 Buy predictions and no Sell predictions.
As a result the target price of 523 € shows a slightly positive potential of 5.55% compared to the current price of 495.5 € for McKesson Corp..
Pros and Cons of McKesson Corp. in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of McKesson Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
McKesson Corp. | 0.880% | -3.269% | -1.246% | 47.508% | 18.647% | 211.774% | 360.529% |
Cardinal Health Inc. | 0.110% | -4.748% | -9.433% | 21.695% | 2.089% | 81.653% | 105.940% |
CVS Health Corp. | -0.440% | -17.280% | -24.528% | -19.021% | -27.499% | -24.964% | 2.729% |
AmerisourceBergen Corp. | -0.120% | -7.595% | -7.327% | 36.480% | 13.095% | 110.152% | 211.592% |
Comments
McKesson Co. (NYSE: MCK) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for MCK provided by MarketBeat
McKesson Co. (NYSE: MCK) had its price target raised by analysts at Citigroup Inc. from $575.00 to $620.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MCK provided by MarketBeat
McKesson Co. (NYSE: MCK) had its price target raised by analysts at Morgan Stanley from $522.00 to $548.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for MCK provided by MarketBeat
News
McKesson (MCK) Q3 2024 Earnings Call Transcript
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
Bigtime medical distributors like McKesson (NYSE: MCK) and Cencora (NYSE: COR) make money by moving drugs and supplies to clinics and pharmacies worldwide. While investors usually look to such